-
October 9, 2017 Lupin receives FDA approval for generic Corgard® Tablets
-
September 29, 2017 Lupin receives FDA approval for generic Acticlate® Tablets
-
September 25, 2017 Lupin receives FDA approval for generic Clobex® Lotion
-
September 18, 2017 Lupin appoints Jim Loerop as Chief Corporate Development Officer
-
September 13, 2017 Lupin receives FDA approval for generic Flagyl® Tablets
-
September 11, 2017 Lupin receives FDA approval for generic Vibra-Tabs® Tablet
-
September 4, 2017 Lupin launches generic Benicar® tablets in the US
-
August 31, 2017 Lupin launches generic Fosrenol Chewable Tablets in the US
-
August 30, 2017 NHI Drug Price Listing for Bipresso® Extended Release Tablets for the Improvement of Depressive Symptoms Associated with Bipolar Disorder Announced
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications